• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub

慢性肾脏病患者中平均血小板体积/淋巴细胞比值与冠状动脉病变程度的临床应用价值

李迎宾, 李胜开

李迎宾, 李胜开. 慢性肾脏病患者中平均血小板体积/淋巴细胞比值与冠状动脉病变程度的临床应用价值[J]. 临床肾脏病杂志, 2022, 22(5): 365-369. DOI: 10.3969/j.issn.1671-2390.2022.05.003
引用本文: 李迎宾, 李胜开. 慢性肾脏病患者中平均血小板体积/淋巴细胞比值与冠状动脉病变程度的临床应用价值[J]. 临床肾脏病杂志, 2022, 22(5): 365-369. DOI: 10.3969/j.issn.1671-2390.2022.05.003
Li Ying-bin, Li Sheng-kai. Clinical value of mean platelet volume/lymphocyte ratio and degree of coronary artery disease in patients with chronic kidney disease[J]. Journal of Clinical Nephrology, 2022, 22(5): 365-369. DOI: 10.3969/j.issn.1671-2390.2022.05.003
Citation: Li Ying-bin, Li Sheng-kai. Clinical value of mean platelet volume/lymphocyte ratio and degree of coronary artery disease in patients with chronic kidney disease[J]. Journal of Clinical Nephrology, 2022, 22(5): 365-369. DOI: 10.3969/j.issn.1671-2390.2022.05.003

慢性肾脏病患者中平均血小板体积/淋巴细胞比值与冠状动脉病变程度的临床应用价值

详细信息
    通讯作者:

    李胜开,Email:lsk2869388@126.com

Clinical value of mean platelet volume/lymphocyte ratio and degree of coronary artery disease in patients with chronic kidney disease

  • 摘要: 目的 探讨慢性肾脏病患者中平均血小板体积/淋巴细胞比值(mean platelet volumeto lymphocyte ratio,MPVLR)与冠状动脉病变程度的关系及其临床意义。方法 回顾性分析近6年来于徐州医科大学附属医院确诊慢性肾脏病并完善冠状动脉造影的111例患者的临床资料。采用Gensini积分评估冠状动脉病变程度,将资料分为3组,A组(轻度,29例) 0~30分; B组(中度,23例)31~60分,C组(重度,59例) >60分。首先通过单因素分析得出影响冠状动脉病变的相关因素,在此基础上采用有序Logistic回归分析明确危险因素和保护因素,最后采用受试者操作特征曲线判断其预测价值。结果 单因素分析显示,3组患者的一般资料差异无统计学意义(P>0.05),实验室指标中的白蛋白、尿酸、高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)、MPVLR差异有统计学意义(P<0.05)。高水平MPVLR是高Gensini积分的独立危险因素(OR=1.115,95% CI 1.009~1.239,P=0.047),HDL-C是其保护因素。结论 慢性肾脏病患者中,高MPVLR是冠脉病变程度严重的独立危险因素,同时具有预测冠脉病变程度的应用价值。
    Abstract: Objective To investigate the relationship between mean platelet volume to lymphocyte ratio(MPVLR) and the degree of coronary artery disease in patients with chronic kidney disease (CKD) and its clinical significance. Methods The clinical data of 111 patients with chronic kidney disease diagnosed by coronary angiography in our affiliated hospital in recent 6 years were analyzed retrospectively. The Gensini scoring was used to assess the severity of coronary artery disease. The data were divided into three groups:group A(mild, 29 cases) had 0-30 points; Group B(moderate, 23 cases) had 31-60 points, and group C(severe, 59 cases) had >60 points. First, the related factors affecting coronary artery disease were analyzed by univariate analysis. On this basis, the risk factors and protective factors were determined by Logistic regression analysis. Finally, the predictive value was determined by ROC curve. Results Univariate analysis showed that there was no significant difference in general data among the 3 groups(P>0.05), but there were significant differences in laboratory indicators such as albumin, uric acid, high density lipoprotein cholesterol(HDL-C) and MPVLR(P<0.05). High MPVLR level was an independent risk factor for high Gensini integration(OR=1.115, 95% CI 1.009-1.239, P=0.047), and HDL-C was a protective factor. Conclusions In patients with chronic kidney disease, high MPVLR is an independent risk factor for the severity of coronary artery disease, and has the application value in predicting the severity of coronary artery disease.
  • [1]

    Mills KT,Xu Y,Zhang WD,et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010[J]. Kidney Int, 2015, 88(5):950-957. DOI:10. 1038/ki. 2015. 230.

    [2] 王善志, 朱永俊, 李国铨, 等. 中国成人慢性肾脏病患病率的Meta分析结果及对比[J]. 中华肾脏病杂志, 2018, 34(8):579-586. DOI:10. 3760/cma. j. issn. 1001-7097. 2018. 08. 004.

    Wang SZ, Zhu YJ, Li GQ, et al. Prevalence of chronic kidney disease in Chinese adults:results from Meta-analysis[J]. Chin J Nephrol, 2018, 34(8):579-586. DOI:10. 3760/cma. j. issn. 1001-7097. 2018. 08. 004.

    [3]

    Wu MT, Rementer C, Giachelli CM. Vascular calcification:an update on mechanisms and challenges in treatment[J]. Calcif Tissue Int, 2013, 93(4):365-373. DOI:10. 1007/s00223-013-9712-z.

    [4]

    Masson I, Flamant M, Maillard N, et al. MDRD versus CKDEPI equation to estimate glomerular filtration rate in kidney transplant recipients[J]. Transplantation, 2013, 95(10):1211-1217. DOI:10. 1097/TP. 0b013e318288caa6.

    [5]

    Rampidis GP, Benetos G, Benz DC, et al. A guide for Gensini Score calculation[J]. Atherosclerosis, 2019, 287:181-183. DOI:10. 1016/j. atherosclerosis. 2019. 05. 012.

    [6]

    de Nicola L, Zoccali C. Chronic kidney disease prevalence in the general population:heterogeneity and concerns[J]. Nephrol Dial Transplant, 2016, 31(3):331-335. DOI:10. 1093/ndt/gfv427.

    [7]

    Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control:a systematic analysis of populationbased studies from 90 countries[J]. Circulation, 2016, 134(6):441-450. DOI:10. 1161/CIRCULATIONAHA. 115. 018912.

    [8]

    Xie Y, Bowe B, Mokdad AH, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016[J]. Kidney Int,2018,94(3):567-581. DOI:10. 1016/j. kint. 2018. 04. 011.

    [9]

    Whaley-Connell A, Kurella Tamura M, McCullough PA. A decade after the KDOQI CKD guidelines:impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)[J]. Am J Kidney Dis, 2012, 60(5):692-693. DOI:10. 1053/j. ajkd. 2012. 08. 008.

    [10] 刘洋, 杨蕊, 袁红斌, 等. 中性粒细胞/淋巴细胞比率在慢性肾衰患者中的应用价值[J]. 中华保健医学杂志, 2017, 19(2):177-179. DOI:10. 3969/. issn. 1. 674-3245. 2017. 02. 028.

    Liu Y, Yang R, Yuan HB, et al. The value of neutrophil/lymphocyte ratio in patients with chronic renal failure[J]. Chin J Heal Care Med, 2017, 19(2):177-179. DOI:10. 3969/. issn. 1674-3245. 2017. 02. 028.

    [11]

    Bal Z, Bal U, Okyay K, et al. Hematological parameters can predict the extent of coronary artery disease in patients with endstage renal disease[J]. Int Urol Nephrol, 2015, 47(10):1719-1725. DOI:10. 1007/s11255-015-1073-2.

    [12]

    Ridker PM,Everett BM,Thuren T,et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med,2017,377(12):1119-1131. DOI:10. 1056/NEJMoa1707914.

    [13]

    Kilic A,Kurtul A. RETRACTED:mean platelet volume-tolymphocyte ratio as a novel marker for severity and complexity of coronary atherosclerosis in patients with acute coronary syndrome[J]. Angiology,2017:2017Jan1;3319717724274. DOI:10. 1177/0003319717724274.

    [14]

    Papayianni A, Alexopoulos E, Giamalis P, et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients:association with inflammation,dyslipidaemia, and vascular events[J]. Nephrol Dial Transplant, 2002, 17(3):435-441. DOI:10. 1093/ndt/17. 3. 435.

    [15] 黄玉红, 王洁. 慢性肾脏病所致微炎症状态的研究进展[J]. 右江民族医学院学报, 2021, 43(1):128-133. DOI:10. 3969/j. issn. 1001-5817. 2021. 01. 028.

    Huang YH,Wang J. Research progress of microinflammatory state caused by chronic kidney disease[J]. J Youjiang Med Univ Natl, 2021, 43(1):128-133. DOI:10. 3969/j. issn. 1001-5817. 2021. 01. 028.

    [16]

    Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure[J]. J Am Soc Nephrol, 1999, 10(7):1606-1615. DOI:10. 1681/ASN. V1071606.

    [17]

    Hung GU, Ko KY, Lin CL, et al. Impact of initial myocardial perfusion imaging versus invasive coronary angiography on outcomes in coronary artery disease:a nationwide cohort study[J]. Eur J Nucl Med Mol Imaging, 2018, 45(4):567-574. DOI:10. 1007/s00259-017-3872-4.

    [18] 刘勇, 张道友. 慢性肾脏疾病与高尿酸血症的相关性研究[J]. 辽宁医学院学报, 2014, 35(5):20-24, 108. DOI:10. 13847/j. cnki. lnmu. 2014. 05. 008.

    Liu Y, Zhang DY. Correlation between chronic kidney disease and hyperuricemia[J]. J Liaoning Med Univ, 2014, 35(5):20-24, 108. DOI:10. 13847/j. cnki. lnmu. 2014. 05. 008.

    [19]

    Hisatome I, Li PL, Miake J, et al. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease-Japanese guideline on the management of asymptomatic hyperuricemia[J]. Circ J, 2021, 85(2):130-138. DOI:10. 1253/circj. CJ-20-0406.

    [20]

    Yang Y, Lin LH, Gao M, et al. Association between the serum uric acid level and the severity of coronary artery disease in a retrospective study of China nondialysis CKD patients[J]. Metab Syndr Relat Disord,2020,18(4):206-211. DOI:10. 1089/met. 2019. 0114.

    [21]

    Borghi C, Domienik-Karłowicz J, Tykarski A, et al. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk:2021 update[J]. Cardiol J, 2021, 28(1):1-14. DOI:10. 5603/CJ. a2021. 0001.

    [22]

    Schalk BWM, Visser M, Bremmer MA, et al. Change of serum albumin and risk of cardiovascular disease and all-cause mortality:longitudinal Aging Study Amsterdam[J]. Am J Epidemiol, 2006, 164(10):969-977. DOI:10. 1093/aje/kwj312.

    [23]

    Don BR, Kaysen G. Serum albumin:relationship to inflammation and nutrition[J]. Semin Dial, 2004, 17(6):432-437. DOI:10. 1111/j. 0894-0959. 2004. 17603. x.

    [24]

    Tuteja S, Rader DJ. High-density lipoproteins in the prevention of cardiovascular disease:changing the paradigm[J]. Clin Pharmacol Ther, 2014, 96(1):48-56. DOI:10. 1038/clpt. 2014. 79.

  • 期刊类型引用(3)

    1. 邱素娟,陈文青. 慢性肾脏病3~5期患者凝血功能变化及高凝状态危险因素分析. 中外医学研究. 2024(32): 79-82 . 百度学术
    2. 张莹,张生燕,孟敏,王秀敏. MPVLR与消化性溃疡并发上消化道出血的关系. 青岛大学学报(医学版). 2024(05): 747-750 . 百度学术
    3. 李芝萍,刘虹,林佳丽. WMR和Hcy对老年急性ST段抬高型心肌梗死患者预后的预测价值. 全科医学临床与教育. 2023(12): 1096-1100 . 百度学术

    其他类型引用(0)

计量
  • 文章访问数:  158
  • HTML全文浏览量:  0
  • PDF下载量:  216
  • 被引次数: 3
出版历程
  • 收稿日期:  2021-08-19
  • 网络出版日期:  2023-05-11
  • 刊出日期:  2022-05-27

目录

    /

    返回文章
    返回